Icon

Mirvaso - (EQ 0.33% BASE; Gel, Topical)

Brimonidine Galderma
EQ 0.33% BASE; Gel, Topical
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
Less Than 5
Indicated for the topical treatment of persistent (nontransient) erythema of rosacea in adults 18 years of age or older.
Yes
******* ** *** ***** ** **** **** ** **** ******* '***(*** **, ****); '***(*** **, ****), '***(*** **, ****), '*** (*** **, ****); '***(*** **, ****), '*** (*** **, ****) *** *** ************ *********. ***** ******* **** ***** **** ** **** *** **** ******* *** *** ************ *********. ****** *** ****** ** ** ****** ****, ********** *** ******* **** **** ******* *** ******* ***** *** ***** ** ********* *** *** *****. **** ******* **** *** ******* *********** ** ** ** * ******* *** ***********.
Mirvaso Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12
******* ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* *******
******* ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** **, **** ******* **** ****** *** ****
******* ** \ ** *** **, **** ******* ******** ******** *** **, ****
  1. *** *, **** : ******* ******** ******** ***** *** **** ** **** ******* '***(*** **, ****); '***(*** **, ****), '***(*** **, ****), '*** (*** **, ****); '***(*** **, ****), '*** (*** **, ****).
  2. *** **, **** : ******** ***** * **** ******* ******* ** ******** ***** ** ********.
  3. *** **, **** : ******** ***** * **** ******* ******* ** ******** ***** ** ******** ** ******* ***** **** ** **** ******* '***(*** **, ****); '***(*** **, ****), '***(*** **, ****), '*** (*** **, ****); '***(*** **, ****), '*** (*** **, ****).
  4. *** *, **** : ********** *** ********* **** ******* ***** *** ***** ** ********* *** *** *****.
  5. *** *, **** : ********** *** ********* **** ******* ***** *** ***** ** ********* *** *** *****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.